Formulation and Drug Delivery

FDA and FTC Collaborate on Competitive Biologics Market

February 06, 2020

The two agencies are collaborating to support a robust biologics marketplace by taking steps to deter anti-competitive business practices.

Guidance on Biosimilar Licensure

February 06, 2020

FDA published draft guidance for applicants seeking licensure of a proposed biosimilar or proposed interchangeable biosimilar.

FDA Approves Seqirus’ Adjuvanted, Cell-Based Pandemic Influenza Vaccine

February 04, 2020

The vaccine is designed to provide active immunity against the influenza A (H5N1) strain and can be easily deployed in a pandemic event.

Improving Solubility of Cannabinoids

February 02, 2020

Lipid-based solutions offer a natural approach to improving the solubility of cannabinoid-derived products.

Quantitative Rupture Testing of Soft Gelatin Capsules: Understanding Aberrant Results

February 02, 2020

This paper discusses what causes cross-linking, how cross-linking is addressed with addition of enzymes, and consideration for occasional high results that can be obtained during release testing.

More Capacity and Technology Translate to More Options

February 01, 2020

The need for manufacturing speed inspires contract manufacturers to explore advanced processing technologies.

Daiichi Sankyo Licenses ERS Genomics’ CRISPR Gene Editing Tech

January 31, 2020

Pharmaceutical Technology's In the Lab eNewsletter

The license gives Daiichi Sankyo access to ERS Genomics’ genome-editing technology for internal R&D initiatives.

Otsuka, PhoreMost Team Up for Drug Discovery

January 31, 2020

Pharmaceutical Technology's In the Lab eNewsletter

Otsuka will use PhoreMost’s phenotypic screening platform to identify new targets for drug development, with a focus on gene therapy.

Johnson & Johnson to Develop a Vaccine Candidate Against Novel Coronavirus

January 30, 2020

J&J’s Janssen Pharmaceutical Companies seeks to develop a vaccine candidate against the novel coronavirus.

FDA Promotes Gene Therapy with New Guidance Documents

January 28, 2020

The agency has published seven guidance documents directed at the development and manufacture of gene therapies.